MSACL 2011

3rd Annual Conference

Session Program: SHORT Abstracts (2.5MB PDF) | Session Program: LONG Abstracts (12MB PDF)

Submitted Abstracts: 245

Feb 5-9, 2011

** FINAL SCHEDULE **

	Sunday Feb 6
7:00 AM	BREAKFAST (provided)
	Short Courses
9am - 4pm	Two Day	Fundamental LC-MS/MS and Methods Development Lead: Jack Henion	Development and Validation of Quantitative LC-MS/MS Assays for Use in Clinical Diagnostics Lead: Russ Grant
	One Day	Chromatographic Applications for Mass Spectrometry Lead: Brian Crow with Megan McGuigan	Metabolomics Lead: Gary Siuzdak with Gary Patti	Proteomics Lead: Andy Hoofnagle with Mike MacCoss, Nathan Yates
	LUNCH provided between 11:30am and 1:30pm Exact break time is at the discretion of instructor
	Opening of General Scientific Session
3:00 PM	OPENING RECEPTION IN EXHIBIT HALL with Super Bowl XLV Coverage
	Sunday Evening Plenary Session Chair: Russ Grant
7:30 PM	The Promise Of The Cacao Flavanol (-)-Epicatechin As A Therapeutic Agent Francisco Villarreal University of California, San Diego Confirmed
8:30 PM	Hospitality Suite Outdoor Heated Patio Overlooking San Diego Marina

	Monday Feb 7
7:00 AM	BREAKFAST (provided)
8:00 AM	Opening Remarks and Welcome David Herold VA Healthcare San Diego and University of California, San Diego
	Monday Morning Plenary Session Chair: David Herold
8:10 AM	Innovative Mass Spectrometry Technology for the Identification of Cancer Immunotherapeutics Donald F. Hunt University of Virginia Confirmed
9:10 AM	Micro-Algae for the Production of Biofuels and Bio-Products Stephen Mayfield San Diego Center for Algae Biotechnology, UCSD Confirmed
10:00 AM	COFFEE BREAK
	Small Molecule Analysis Chair: Brett Holmquist Track 1	Applied Metabolomics Chair: Gary Siuzdak Track 2	Chemical Warfare Agents Chair: Ben Blount Track 3
10:30 AM	Steroid Analysis in Clinical Diagnostics: Selectivity, Sensitivity and Speed Russell Grant LabCorp, Inc. Confirmed	Building a Sustainable Biomarker Pipeline by Comprehensive Metabolite Profiling Volker Liebenberg Metanomics Health Confirmed	Biomarker Analysis for Verification of Chemical Warfare Agent Exposure in Humans and Animal Models Benedict R. Capacio US Army Confirmed
11:00 AM	Development of an LC-MS/MS Method for 1,25-Dihydroxyvitamin D for Use in the Clinical Laboratory Frederick G. Strathmann University of Washington Confirmed	The Metabolomic Landscape of Chemotherapy Resistance Anders Nordstrom Karolinska Institute, Sweden Confirmed	An Improved Procedure for the Rapid Analysis of Lewisite Metabolites in Urine by LC-ICP-MS Stephen Donovan Pennsylvania Department of Health Confirmed
11:30 AM	Developing and Validating a LC-MS/MS Method for Concurrently Measuring Cortisol, 11-Deoxycortisol, DHEA, Androstenedione, Progesterone and 17-Hydroxyprogesterone: Challenges and Possible Applications Victor Goh UCLA at Harbor Confirmed	Metabolomics of Bacterial Infection Gary Patti The Scripps Research Institute Confirmed	Development of a Quantitative, High Throughput OP-Nerve Agent Adduct Method Jennifer Sporty CDC Confirmed
	PosterSplash Small Molecule Analysis	Poster Splash Metabolomics	Poster Splash Various
12:00 PM	1. Interferences in an LC-MS/MS Steroid Assay: Systematic Reduction of Possible Endogenous Interferences from Database Searches and Examination of an Exogenous Interference from Sample Collection Jason Cournoyer PerkinElmer Life Sciences Confirmed 11. An LC-MS-based Metabolomics Approach for the Development of Diagnostic Tools for Onchocerciasis Judith Denery The Scripps Research Institute Confirmed 21. The Effect of Temperature and Storage Duration on the Stability of Environmental Contaminants Metabolites Paramjit Behniwal California Department of Public Health Confirmed
12:06 PM	3. Quantitative Analysis of Underivatized 1,25-Dihydroxyvitamin D3 and D2 in Blood by UHPLC and Triple Quadrupole Mass Spectrometer Utilizing Ion Funnels Technology Andre Szczesniewski Agilent Technologies, Inc. Confirmed 13. Search for Colon-derived Uremic Toxins in Humans Using an Orbitrap-based Metabolomics Platform Pavel A. Aronov Stanford University Confirmed 23. Ultra High Resolution Mass Spectrometric Determination of the Marine Toxins, Azaspiracids, in Plasma Zuzana Skrabakova PROTEOBIO Confirmed
12:12 PM	5. Method Optimization for High-Throughput 25-OH Vitamin D Analysis: The Devil is in the Details Julia Drees Kaiser Permanente Confirmed 15. Metabolomics: A Tool for Early Detection of Toxicological Effects and an Opportunity for Biology-based Grouping of Chemicals Hajo Schiewe Metanomics Health / BASF SE Confirmed 25. An Investigation of Deuterium Scrambling in Stable-Labeled Internal Standards during LC-MS/MS Analysis Derrell Johnson Cerilliant Corporation Confirmed
12:18 PM	7. Simple and Rapid Sample Preparation for 25OH-VitaminD3/D2 using an Immobilized Liquid Christiane Zaborosch Zuerich University of Applied Sciences, Switzerland Confirmed 17. Targeted Lipidomics: High-Throughput Quantitation of Several Hundreds of Lipid Metabolites in Plasma Samples via Flow-Injection ESI-MS/MS Diane Schmiederer Biocrates Life Sciences AG Confirmed 27. Development of a Synthetic Protein Quality Control (QC) Standard for the Assessment of Sample Proteolysis Reproducibility Bryan Krastins ThermoFisher Scientific Confirmed
12:24 PM	9. Measurement of 25-Hydroxyvitamin D3 and C3-Epi-25-hydroxyvitamin D3 using UPLC-MS/MS in the Adult Population Lisa Calton Waters Corporation Confirmed 19. Metabolomic Fingerprinting of Three Strains of Rat using Ultra High Resolution Time-of-Flight Mass Spectrometry -- Qualitative and Semi-Quantitative Comparison of Fat, Diabetic and Control Zucker Rats Jeffrey S. Patrick Leco Corporation Confirmed 29.Determination of Dialkyl Phosphate Metabolites of Organophosphate Pesticides in Human Urine by Gas Chromatography/High Resolution Mass Spectrometry Dongli Wang California Department of Public Health Confirmed
12:30 PM	LUNCH (provided) Pick it up before attending a workshop. LUNCH & LEARN: Industrial Workshops 12:45 - 1:45 PM Improving Confidence and Productivity in Endocrine and Pain Management Drug Assays Thermo Scientific - Register Track 1: Harbor Ballroom Improving Measurement of Protein Biomarkers by Mass Spectrometry: Methods and Workflows & Quantitative Analysis of Underivatized 1,25-Dihydroxyvitamin D3 and D2 in Blood by UHPLC and Triple Quadrupole Mass Spectrometer Utilizing Ion Funnel Technology Agilent Technologies - Register Track 2: Harbor Ballroom Meeting the Challenge: LC-MS/MS Solutions for the Clinical Research Laboratory AB SCIEX - Register Track 3: Harbor Ballroom 30 Years of Steroid Analysis: From RIA to Turboflow LC-MSMS PerkinElmer Executive 1 Truth in Measurement – LC/MS/MS in the Clinical Laboratory Waters - Register Executive 2 Novel Diagnostic Kits for LC-MS/MS: From Research to Daily Routine Analysis ChromSystems Executive 3 EXHIBITS & POSTERS in the Exhibit Hall
	Testosterone Measurement By Mass Spectrometry Chair: Shalender Bhasin Track 1	How Patents, the FDA, and Multiplexed Assays are Changing Clinical Mass Spectrometry Chair: Steve Master Track 2	Microbiology Chair: Yi-Wei Tang Track 3
3:00 PM	Population-Based Reference Ranges for Testosterone in Men Shalender Bhasin Boston University Confirmed	Combining Multiple Biomarkers - More is Usually Better - Up to a Point Steve Skates Massachusetts General Hospital Confirmed	Mass Spectrometry Biotyper System Identifies Enteric Bacterial Pathogens Directly from Colonies Grown on Selective Stool Culture Media Yi-Wei Tang Vanderbilt University Confirmed
3:30 PM	CDC Testosterone Standardization Project - A Progress Report Hubert Vesper CDC Confirmed	Are Multiplex Assays Approvable? Considerations for Obtaining FDA Clearance or Approval on Multi-Marker Tests Mya Thomae Myraqa, Inc. Confirmed	Characterizing the Adaptation of P. aeruginosa to the Cystic Fibrosis Lung Using GCxGC-TOF and SESI-MS Heather D. Bean University of Vermont Confirmed
4:00 PM	Clinical Testosterone Analysis for the Masses: Taking Testosterone Testing to the Next Level Matthew Crawford LabCorp Confirmed	Keeping Multiplex Assays in Control Stephen R. Master University of Pennsylvania Confirmed	A PCR-ESI/Mass Spectrometry Solution for Detection and Identification of Unculturable Pathogens Mark Eshoo Ibis Biosciences Confirmed
	Poster Splash Small Molecule	Poster Splash Biomarkers	Poster Splash Microbiology
4:30 PM	2. Sensitive and Specific Quantitation of 1α, 25-Dihydroxy Vitamin D3 and Analogs using LC-MS/MS and Labeling Chemistry Subhakar Dey AB SCIEX Confirmed 12. Development of Human Serum N-Glycan Library for Rapid Identification in Disease Biomarker Discovery Using nanoLC-MS Danielle Aldredge University of California, Davis Confirmed 22. Generating a Library of Human Microbiome-derived Microorganisms to Discover Novel Natural Products Matthew Hamby UCSD Confirmed
04:36 PM	4. The Analysis of Testosterone by LC-MS/MS: A Comparison to Immunoassay John McFarlane AB SCIEX Confirmed 14. Comparative Analysis of Serum and Tissue Samples from Cervical Cancer Patients for Biomarker Discovery Natalia Govorukhina University Groningen Confirmed 24. Mass Spectrometry-based MALDI Biotyper System for Rapid and Reliable Yeast Species Identification Directly from Positive Blood Culture Media Yingjun Yan Vanderbilt University Confirmed
04:42 PM	6. Prototype ARCHITECT® 2nd Generation Testosterone Immunoassay Compared to LC-MS/MS Stuart Blincko Abbott Diagnostics Confirmed 16. Quantitative Analysis of Hepcidin in Biofluids and its Role in Diagnosis and Monitoring of Hemochromatosis and Anaemia Ian Mullaney School of Pharmacy, Murdoch University Confirmed 26. Rapid Detection of Salmonella by Selective Enrichment and Mass Spectrometry-Based MALDI Biotyper Markus Kostrzewa Bruker Daltonik, GmbH Confirmed
04:48 PM	8. Quantitative Analysis of Steroids in Blood by Simultaneous Positive and Negative Ionization using QQQ LC-MS/MS Yanan Yang Agilent Technologies, Inc. Confirmed 18. Development and Validation of an LC-MS/MS Assay for Quantitation of Plasma Asymmetric Dimethylarginine (ADMA), Symmetric Dimethylarginine (SDMA), and Arginine Alan Lueke Mayo Clinic Rochester Confirmed 28. Characterization of a Molecular-Based Assay System (PLEX-ID) for Broad Range Detection of Bacteria, Candida, and Antibiotic Resistance from Blood Culture Bottles Lawrence Blyn Ibis Biosciences Confirmed
04:54 PM	10. LC-MS/MS for Quantification of Total Testosterone in Serum Heng Shi Children's Hospital of Philadelphia Confirmed 20. Assessment of Proteomic Changes in the Rat Brain following 17 beta-estradiol Treatment of Hemorrhagic Shock Kyoko Kojima University of Alabama at Birmingham Confirmed 30. Mass Spectrometry-based Analytical Methods for Adeno-associated Virus (AAV) Gene Therapy Vectors Kim Van Vliet University of Florida Confirmed
5:00 PM	RECEPTION IN EXHIBIT HALL / POSTERS
	Monday Evening Plenary Session Chair: Russ Grant
7:30 PM	Mass Spectrometry-Based Metabolomics as a Unique Biochemical Approach for Therapeutic Discovery Gary Siuzdak The Scripps Research Institute Confirmed
8:30 PM	Hospitality Suite Outdoor Heated Patio Overlooking San Diego Marina

	Tuesday Feb 8
7:00 AM	BREAKFAST (provided)
	Tuesday Morning Plenary Session Chair: Gary Siuzdak
8:00 AM	Mass Spectrometry: Chemistry's Toolset for the 20th Century, Biology's Toolset for the 21st Bruce German University of California, Davis Confirmed
9:00 AM	Should Limitations be Placed on Ownership of Personal Medicine Discoveries? Should Personalized Treatment for an Individual's Genetic or Metabolic Makeup be Classified Differently? Anthony G. Craig Sci-Law Strategies, PC Confirmed
10:00 AM	COFFEE BREAK
	Clinical Toxicology & TDM: State of the Art Chair: Jim Ritchie Track 1	Discovery Proteomics Chair: Jeff Whiteaker Track 2	Regulations and Standards Chair: Hubert Vesper Track 3
10:30 AM	Synthetic Cannabinoids- Identification, Detection, and Quantitation in Blood, Urine and Oral Fluid by LC-MS/MS Matthew McMullin NMS Labs Confirmed	Determination of Protein Turnover in Infants Diagnosed with Respiratory Distress Syndrome using Liquid Chromatography-Selected Reaction Monitoring-Mass Spectrometry Mike MacCoss University of Washington Confirmed	FDA Oversight of Laboratory Developed Tests (LDTs): Where are we and where are we going? Katherine Serrano Food and Drug Administration Confirmed
11:00 AM	General Unknown Screening Using ToF-MS: A Reference Lab Perspective Kevin Shanks AIT Laboratories Confirmed	Biomarker Discovery in Stroke Samples Using a Quantitative, Two-Pass LC-MS/MS Workflow Incorporating ROC Curve Analysis Mary Lopez BRIMS Confirmed	A Mass Spec Method Does Not Necessarily a Reference Method Make – the Role of the Joint Committee for Traceability in Laboratory Medicine Mary M. Kimberly CDC Confirmed
11:30 AM	Development of UPLC-LC-MS/MS Assays for the Newer Antidepressants, Antipsychotics, and their Active Metabolites James C. Ritchie Emory University Confirmed	Building Multidimensional Biomarker Views of Type 2 Diabetes and Comorbidities Based on Protein Microheterogeneity Randall W. Nelson The Biodesign Institute at Arizona State University Confirmed	Clinical and Laboratory Standards Institute (CLSI) Standards and Guidelines Development: Process and Clinical Applications Barbara Goldsmith Clinical and Laboratory Standards Institute Confirmed
	PosterSplash Clinical Toxicology	Poster Splash Proteomics	Poster Splash New Advances
12:00 PM	1. LC-MS/MS Analysis of Opioids in Urine – Significance of Glucuronide Metabolites Deborah French University of California, San Francisco Confirmed 11. A High-Throughput Mass Spectrometric Immunoassay for Intact Insulin, Insulin Metabolites, Synthetic Insulins, C-peptide, and C-peptide Metabolites for Population Proteomics Studies Paul Oran The Biodesign Institute at Arizona State University Confirmed 21. Mapping the Activity of Oncogenic Signaling Networks in FFPE Tissue with Phospho-Specific Liquid Tissue® Mass Spectrometry Todd Hembrough Expression Pathology, Inc. Confirmed
12:06 PM	3. Antifungal Azole Panel by 2D-LC-MS/MS Bingfang Yue ARUP Confirmed 13. Improvements in Peptide MRM Sensitivity Using Multiplex Monoclonal Antibody Capture (SISCAPA) and an Ion Funnel QQQ-MS at Standard Flow Rate N. Leigh Anderson Anderson Forschung Group Confirmed 23. Ultra Performance Mass Spectrometry without Comprise: High Resolving Power Multi-reflecting Time-of-Flight Technology with High Speed Data Acquisition John A. Chakel LECO Corporation Confirmed
12:12 PM	5. LC-MS/MS Observations on the Metabolic Ratio of Oxycodone to Oxymorphone in Urine Samples from Pain Patients David A. Yee University of California, San Diego Confirmed 15. Human Osteocalcin Characterization by Mass Spectrometric Immunoassay (MSIA) Douglas S. Rehder The Biodesign Institute at Arizona State University Confirmed 25.
12:18 PM	7. Automated Toxicology Screening of Biological Specimens Using Deconvolution Reporting Software and GC-MS Instrumentation Alex L. Maggitti, III NMS Labs Confirmed 17. Combined Use of Immunoassay and 2-D LC/MS for the Detection and Identification of Metabolites From Biotherapeutic Pharmacokinetic Samples Robert Murphy CovX, Pfizer Biotherapeutics R&D Confirmed 27. Optimization of Rapid Heavy Metals Blood Analysis for Ultra Low Detection Limits by ICP-MS with ISIS Ryszard Gajek California Department of Public Health Confirmed
12:24 PM	9. An Automated Ion Trap MS-based Screening Solution for Clinical and Forensic Toxicology (Still presenting as a poster, but NO SPLASH) Gary Kruppa Bruker Daltonik, GmbH Confirmed 19. Layered Electrophoretic Transfer – A Method for Pre-Analytic Processing of Histological Sections Liang Zhu National Institutes of Health Confirmed 29. 3-Epi-25-OH-Vitamin D3 in Infants Daniel Fabian Viollier AG Spezialanalysen Confirmed
12:30 PM	LUNCH (provided) Pick it up before attending a workshop. LUNCH & LEARN: Industrial Workshops 12:45 - 1:45 PM Use of Trainer Peptides to Increase the Reproducibility and Robustness of SRM-Based Assays for Clinical Proteomics Research Thermo Scientific - Register Track 1: Harbor Ballroom Nuances of Mass Spectrometry Method Validation PerkinElmer Track 2: Harbor Ballroom Tools to Accelerate Toxicology Workflows AB SCIEX - Register Track 3: Harbor Ballroom Clinical Research Applications of MALDI-TOF Mass Spectrometry: Sepsityper for Rapid ID of Microorganisms from Positive Blood Culture; MALDI Molecular Imaging for Biomarker Discovery and Drug Imaging Bruker Executive 1 Quantitative Reversed Phase LC/MS/MS Analysis of Ethyl Glucuronide and Ethyl Sulfate from Urine & A Multiplexed Method for the Determination of Androgens in Serum and Plasma by HPLC-MS/MS Phenomenex Executive 2 Pressure Cycling Technology (PCT): Next Generation Platform for the Preparation of Biomolecules for Mass Spectrometry Analysis Pressure Biosciences Executive 3 EXHIBITS & POSTERS in the Exhibit Hall
	New Advances Chair: Jack Henion Track 1	Tissue Analysis Chair: Gary Patti Track 2	Metabolic and Newborn Screening Chair: Don Chace Track 3
3:00 PM	TBD Michael Roukes California Institute of Technology Confirmed	Mass Spectrometry Tools and Methods Towards Intra-Operative Decision-Making Justin M. Wiseman Prosolia Confirmed	The Dried-Blood Spot Shop: CDC’s Role in Assuring Quality of Dried-Blood Spot Assays Worldwide Victor DeJesus CDC Confirmed
3:30 PM	Mass Spectrometry Solution to the Multi-parameter Flow Cytometry Challenge Scott Tanner University of Toronto Confirmed	Quantitative Analysis of Growth Factor Receptors and Pathway Activation in FFPE Tumor Tissue REPLACING (Alterations of Striatal Dynorphin Peptide Levels in L-DOPA Induced Dyskinesia Revealed by Imaging Mass Spectrometry WITHDRAWN) Todd Hembrough Expression Pathology, Inc. Confirmed	Performance Evaluation Study of a Second-Tier CAH Newborn Screening Method Utilizing Steroid Profiling by LC-MS/MS Mark Fountain (in place of Patricia Hunt) Texas Department of State Health Services Confirmed
4:00 PM	Automated Liquid Extraction Surface Analysis (LESA) Combined with nano Electrospray Tandem Mass Spectrometry as a Novel Tool for Analyzing Surfaces Jack Henion Advion BioSciences, Inc. Confirmed	A Library of 7000 SRM Assays for the Fast, Sensitive and Reproducible Quantification of N-Glycosites in Tissue and Plasma Samples: The N-Glycosite SRM Atlas Bernd Wollscheid Institute of Molecular Systems Biology, ETH Zurich Confirmed	The Dried "X" Spot: A Keystone Supporting Mass Spectrometry Based Clinical Assays in Metabolic and Newborn Screening Donald Chace Pediatrix Analytical Confirmed
	PosterSplash New Advances	Poster Splash Various	Poster Splash InBorn Errors in Metabolism
4:30 PM	2. Increasing LC-MS Assay Robustness Through Increased Specificity Using High Resolution MRM-like Analysis Christie Hunter AB SCIEX Confirmed 12. Global Phosphoproteomics of Transforming Growth Factor β Stimulated PANC-1 Cells Hyonson Hwang Translational Genomics Research Institute Confirmed 22. Evaluation of Selected Short Chain Acylcarnitines in Blood Spots, Plasma and Urine by UPLC-MS/MS for the Differential Diagnosis of Branched-chain Organic Acidurias Aiping Liu ARUP Institute for Clinical and Experimental Pathology Confirmed
4:36 PM	4. Fully Automated Analysis of PCR Products by High Performance ESI-TOF Mass Spectrometry: A Novel Platform for Clinical Research Jose R. Gutierrez Ibis Biosciences Confirmed 14. α-Galactosidase A (GLA) Activity for Fabry Disease Screening by : Inexpensive, Fast Sample Preparation Sabrina Forni Baylor Research Institute Confirmed 24. Characterization of Plasma and Urine Metabolites in Barth Syndrome Patients Employing LC-MS/MS and GC-MS Strategies Yana Sandlers Kennedy Krieger Institute Confirmed
4:42 PM	6. Mass Spectrometric Immunoassays for Quantitative Determination of Protein Biomarker Isoforms Olgica Trencevska Intrinsic Bioprobes Confirmed 16. Liquid Extraction of Endocannabinoids with Toluene Reduces Matrix Effect and Trans-acylation of 2-Arachidonoyl Glycerol to 1-Arachadinoyl Glycerol Alexander A. Zoerner Hannover Medical School, Germany Confirmed 26. High-Throughput Quantification of Acylcarnitines in Biological Samples by UHPLC MS/MS Azeret Zuniga University of Alberta Confirmed
4:48 PM	8. A Nanotechnology-based Biomarker Strategy for Discovery and Detection Brian Feild Shimadzu Scientific Instruments Confirmed 18. The Utility of Serum LC-MS/TOF Targeted and Non-Targeted Drug and Drug Metabolite Analysis in Solving Poison Control Center Cases Roy Gerona University of California, San Francisco Confirmed 28. Simplified High-Throughput Multiplexed, Multi-Dimensional UHPLC-MS/MS Assay for the Screening Of Lysosomal Storage Disorders in Newborn Dried Blood Spots David Kasper Medical University of Vienna Confirmed
4:54 PM	10. Improving the Efficiency and Throughput of an Enzymatic Digestion of Klotho using Pressure Cycling Technology (PCT) Taha Rezai ThermoFisher Scientific Confirmed 20. Relationship Between the Concentration of Hydrocodone and its Conversion to Hydromorphone in Chronic Pain Patients using LC-MS/MS Urinary Excretion Data Neveen Barakat University of California, San Diego Confirmed 30. Quantification of 7alpha-Hydroxy-4-cholesten-3-one, a Disease Marker for Cerebrotendinous Xanthomatosis, in Human Plasma using Novel Derivatization Chemistry and LC-MS/MS Andrea DeBarber Oregon Health & Science University Confirmed
5:00 PM	RECEPTION IN EXHIBIT HALL / POSTERS
7:30 PM	Tuesday Evening Workshops MSACL 2012 Organizing Committee Chair: David Herold Inborn Errors of Metabolism Chair: Don Chace Regulations and Standards Chair: Hubert Vesper Proteins, Proteomics and Disease Markers Chair: Mike MacCoss Small Molecule, Tox, Environmental Chair: Russ Grant Tissue Analysis by Mass Spec Chair: Jon Burrows Metabolomics Chair: Gary Patti Public Involvement of Scientists in PEER to PATENT Project to Improve Patent Quality Chair: Anthony Craig
8:30 PM	Hospitality Suite Outdoor Heated Patio Overlooking San Diego Marina

	Wednesday Feb 9
7:00 AM	BREAKFAST (provided)
	Toxicology Chair: Rob Fitgerald Track 1	Targeted Proteomics Chair: Nathan Yates Track 2	Novel Approaches to Mass Spectrometry-Based Clinical Measurements Chair: John Barr Track 3
8:00 AM	LC-MS/MS Unknown Screening in a Large-Scale Forensic Toxicology Study: Enlighten the Needle in the Haystack? Pierre-Alain Binz Geneva Bioinformatics Confirmed	Evaluation of Multiplexing Capabilities Using Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry for Quantitation of Peptides Jeff Whiteaker Fred Hutchinson Cancer Research Center Confirmed	Detection, Differentiation, Quantification and Subtyping of Botulinum Neurotoxins in Clinical Samples with Mass Spectrometry John Barr CDC Confirmed
8:30 AM	Simultaneous Multi-Targeted and Unknown Screening of Urine Samples by LC-MS/MS with Automated Library Searching for Compound Identification Michael Jarvis AB Sciex Confirmed	Enhanced Sensitivity of MRM-based Protein Quantitation in Plasma Christoph Borchers University of Victoria Confirmed	Intact Protein Quantification by Mass Spectrometry Mark W. Duncan University of Colorado, Denver Confirmed
9:00 AM	Utilizing LC-MS/TOF to Identify Designer Drugs in the Clinical Laboratory Matt Petrie University of California, San Franciso Confirmed	Quantitative Analysis of IGF-1 by High Resolution Mass Spectrometry Cory Bystrom Quest Diagnostics Nichols Institute Confirmed	Strategies for Bacterial Identification Using Bacteriophage Amplification Detection Coupled with Mass Spectrometry Carrie Pierce Georgia Institute of Technology/CDC Confirmed
9:30 AM	Dilute and Shoot: Comparison of Selected Reaction Monitoring with Full Scan MS/MS for Amphetamines, Opiates and Cocaine Metabolite Robert Fitzgerald VA San Diego/UCSD Confirmed	A Reference Measurement Procedure to Quantify Urinary Albumin Ashley S. Beasley National Institute of Standards and Technology Confirmed	Proteomic Identification of Coccidioidal Antigens from Lung Fluid of Infected Mice: MRM Analysis to Confirm Presence in Biological Fluids Forrest S.E. Helfrich University of Arizona Confirmed
10:00 AM	COFFEE BREAK
	Biomarkers in Drug Discovery: Future Companion Diagnostic Assays Chair: Mike Greig Track 1	Microbes and Infectious Disease Chair: Richard Ill Track 2	Tobacco Exposure Chair: Tom Bernert Track 3
10:30 AM	Personalized Medicine of Thiopurine Therapy in Autoimmune Diseases: Contribution of LC-MS/MS Analysis Thierry Dervieux Exagen Diagnostics Confirmed	Comparative Analysis of PCR Electrospray Ionization Mass Spectrometry to MALDI-ToF Mass Spectrometry for the Identification of Bacteria and Yeast from Positive Blood Culture Bottles Erin J. Kaleta University of Arizona Confirmed	Tobacco Biomarker Measurements by Tandem Mass Spectrometry - Population Exposure Estimates in National Surveys Tom Bernert CDC Confirmed
11:00 AM	Protein Biomarker LC-MS/MS Assays in Translational Pharmacology- from Early Discovery to Proof-of-Concept Clinical Trials Hendrik Neubert Pfizer Confirmed	Masscode Pathogen Detection Platform Craig Monell Agilent Technologies Confirmed	Toenail And Hair Nicotine Biomarkers Research Applications Wael K. Al-Delaimy University of California, San Diego Confirmed
11:30 AM	Glycan Markers for Disease Diagnosis Carlito Lebrilla University of California, Davis Confirmed	Strain Identification of Methicillin-Sensitive Staphylococcus Aureus from a Neonatal Intensive Care Unit using MALDI-ToF Mass Spectrometry Richard R. Drake Eastern Virginia Medical School Confirmed	Mass Spectrometric Methods for Studies of Nicotine Metabolism and Tobacco Carcinogen Exposure - Some Recent Applications in Clinical Research Peyton Jacob University of California, San Francisco Confirmed
12:00 PM	The Impact of Chromatography and High Resolution Mass Spectrometry for Targeted and Non-Targeted Data Analysis Timothy Croley US Food and Drug Administration Confirmed	Identification of Microorganisms by MALDI-TOF MS Profiling Markus Kostrzewa Bruker Daltonik GmbH Confirmed	Biomarkers of Tobacco Smoking-induced Oxidative Stress Ian Blair University of Pennsylvania Confirmed
12:30 PM	LUNCH (provided)
	Sample Preparation and Automation Strategies Chair: Russell Grant Track 1	Discovery Metabolomics Chair: Matthew Greving Track 2	Proficiency Testing Chair: Robert Kobelski Track 3
2:00 PM	Errors in Bioanalysis Due to Phospholipids - Definitive Measurement, Mechanism, and Management Brian Rappold LabCorp Confirmed	Metabolomics of Plasma Reveal Novel Endogenous Metabolites Involved in Coagulation Sunia Trauger The Scripps Research Institute Confirmed	The Landscape of Mass Spectrometry in the Clinical Laboratory Jerry Thomas CDC/NCEH Confirmed
2:30 PM	High-Throughput Automated System for SISCAPA Sample Preparation for Clinical Proteomics Matthew Rosenow Translational Genomics Research Institute Confirmed	Metabolic Predictors of Insulin Sensitivity Predict Progression to Impaired Glucose Tolerance Walter Gall Metabolon Confirmed	What Goes on Behind the Scenes in CAP Proficiency Testing? Gary Horowitz Beth Israel Deaconess Medical Center Confirmed
3:00 PM	The Filter Paper Matrix: The New Frontier of Blood Lead Screening Kansas Department of Health and Environmental Laboratories Jon Brady Kansas Department of Health and Environmental Laboratories Confirmed	Evaluating the Intestinal Health of Infants by Analysis of Excreted Oligosaccharides Maria Lorna A. De Leoz University of California, Davis Confirmed	Proficiency Testing: Nuisance, Regulatory Requirement, or Critical Tool? Robert Kobelski CDC Confirmed
3:30 PM	A Comparison of Immobilized Liquids Used for Sample Clean-up Prior to LC/MS Analysis of Antidepressants and Active Metabolites Rob Wohleb ILE, Inc. Confirmed	High Throughput and Standardized LC-MS/MS Steroid-Quantification for Clinical Metabolomics Therese Koal Biocrates Life Sciences, AG Confirmed	Proficiency Testing (PT) as a Quality Tool: Values and Limitations Noel Stanton Wisconsin State Laboratory of Hygiene Confirmed
4 - 8 PM	Hospitality Suite Closing Reception Outdoor Heated Patio Overlooking San Diego Marina Buffet Dinner

Poster Presentations

POSTERS: Monday Feb 7
Exhibit Hall: Attended from 2:00-3:00 PM
Includes All PosterSplashes Presented from the Podium Between 12:00-12:30PM
	31. Metabolic Ratios of Excreted Pain Medications Obtained by LC-MS/MS Analysis can be used to Determine Aberrant Drug Metabolism Amadeo Pesce Millennium Laboratories Confirmed	33. Using Exactive Mass Spectrometry for Comprehensive Medication Screening to Monitor Polypharmacy in the Pain Management Population Bridgit Crews Millennium Research Institute Confirmed	35. Use of a Dual Liquid Chromatography-Mass Spectrometry Method for Screening and Confirmatory Testing of Drugs of Abuse in an Urban HIV-Positive Emergency Room Population Autumn Breaud The Johns Hopkins University Confirmed
	37. A Fully Automated Turbulent Flow Liquid Chromatography Isotope Dilution Mass Spectrometry (LC-IDMS) Method for Quantitation of Voriconazole in Human Serum Robert Harlan Johns Hopkins University Confirmed	39. Clinical Validation of a Multiplexed EGFR Signaling Pathway Assay in FFPE Colorectal Cancer Tissue Todd Hembrough Expression Pathology, Inc. Confirmed	41. Ultra-fast, Simultaneous Analysis of a Panel of Benzodiazepines in Human Urine Using an SPE-TOF System Vaughn Miller BIOCIUS Life Sciences Confirmed
	43. Fast and Sensitive Amino Acid Analysis using aTRAQ Derivatization and UPLC-MS/MS Brent Dawson AB SCIEX Confirmed	45. Efficient and Sensitive Analysis of THC in Oral Fluid by LC-MS/MS Utilizing CEDIA® THC OFT Test Kit Kristine Van Natta ThermoFisher Scientific Confirmed	47. The Effect of Mass Spectrometric Variance of Busulfan Concentration Measurement on the Pharmacokinetic Area Under the Curve: Analytical Variance with Clinical Implications Matthew T. Olson Johns Hopkins Hospital Confirmed
	49. Extraction of Tamoxifen and Metabolites from Urine and Plasma using Supported Liquid Extraction (SLE) prior to UPLC-MS/MS Analysis Lee Williams Biotage GB Limited Confirmed	51. Vitamin D and Metabolites: Evaluation of Supported Liquid Extraction (SLE) Prior to UPLC-MS/MS Analysis Lee Williams Biotage GB Limited Confirmed	53. Field Flow Fraction Separation and On-Line Mass Spectrometric Detection of Organelles from Heart Cells Dale Chatfield San Diego State University Confirmed
	55. Rapid Protein Extraction and Trypsin Digestion with Pressure Cycling Technology (PCT) Paul H Pevsner University of Missouri School of Medicine Confirmed	57. Sensitive LC-MS/MS Method for Determination of 25-Hydroxyvitamin D3 and its C3-Epimer after Diels-Alder Derivatization Evgueni Fedorov Warnex Bioanalytical Services Confirmed	59. A Comparison Study of Semi-Porous and Porous Particles for Fast LC-MS-MS Analysis Using Conventional LC Instrumentation Rick Link Supelco/Sigma-Aldrich Confirmed
	61. Toxicological Screening of 80 Drugs in Urine Samples Using the High Resolution Exactive LC/MS Orbitrap Mass Spectrometer Coupled to Online Extraction and Turbulent Flow Chromatography Touraj Shokati UC Denver Confirmed	63. Mutation and Tissue Preferential Accumulation of Glucosylceramides in Gaucher Disease Mouse Model Wujuan Zhang Cincinnati Children's Hospital Confirmed	65. Increased Process Efficiency in UPLC-MS/MS Data Review Through Use of Rules-Based Software Automation Joseph Ervin AIT Laboratories Confirmed
	67. Use of Waters Systematic Toxicology Analysis with Chromalynx in the Hospital Laboratory John Shepherd Hull Royal Infirmary Confirmed	69. Observations on the Metabolism of Morphine to Hydromorphone in Pain Patient Urinary Excretion Data using LC-MS/MS Michelle Hughes University of California, San Diego Confirmed	71. Determination of Conjugated and Unconjugated Tapentadol (Nucynta®) and N-Desmethyltapentadol in Authentic Urine Specimens by UPLC/MS/MS James Bourland Ameritox Confirmed
	73. An LC-MS/MS Analytical Method for Barbiturate Analysis in Urine Theresa Lee AB SCIEX Confirmed	75. An LC-MS/MS Analytical Method for Pregabalin and Tapentadol Analysis in Urine and Plasma Theresa Lee AB SCIEX Confirmed	77. Urine and Saliva Cortisol Measurement by LC-MS/MS Hendrick E van Deventer NIH Clinical Center Confirmed
	79. Molecular Weight Exclusion of Proteins Using Turbulent Flow Chromatography Joseph Herman ThermoFisher Confirmed
Exhibit Hall: Attended from 6:30-7:30 PM
Includes All PosterSplashes Presented from the Podium Between 4:30-5:00PM
	32. Increasing Throughput by Multiplexing Drugs of Abuse Analysis Michael Jarvis AB SCIEX Confirmed	34. Recent Advances in Measuring VOCs in Blood as Biomarkers of Exposure Ben Blount CDC Confirmed	36. Transfer of 25-Hydroxyvitamin D2/D3 Analysis in Human Plasma to Core-Shell Columns to Improve Sample Throughput in a Clinical Laboratory Philip J. Koerner Phenomenex Confirmed
	38. A Simplified and Streamlined Approach to Solid Phase Extraction for the New SAMHSA Drugs of Abuse Panel Michael Rummel Phenomenex Confirmed	40.	42. Development of a Mass Spectrometry Method to Identify Specific Peptides of a Novel Prostate Cancer Associated Retrovirus Jeanne Rhea Emory University Confirmed
	44. Confirmatory Quanitation of Benzodiazepines in Post-Mortem Matrices using HPLC/MS with Online Sample Preparation Kathryn Preston Thermo Fisher Scientific Confirmed	46. Rapid Extraction of Four Immunosuppressants from Blood for Sequential Sample Preparation Prior LC-MS/MS Analysis Michael Vogeser Hospital of the University of Munich Confirmed	48. LC-MS/MS and GC-MS methods for Phthalates and Bisphenol-A William Ofsa NMS Labs Confirmed
	50.	52. 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 Analysis Using a QTRAP® 5500 Tandem Mass Spectrometer and the MPX™-2 High Throughput Multiplexed HPLC System Jesse C. Seegmiller AB SCIEX Confirmed	54. MALDI and LCMS Identifications of Protein and ICP-MS Identification of Metal Biomarkers of Ionizing Radiation Paul H Pevsner University of Missouri School of Medicine Confirmed
	56. Benign vs. Malignant Colorectal Polyps-Mass Spectrometry Diagnosis Paul H Pevsner University of Missouri School of Medicine Confirmed	58. Using 200 µm ID cHiPLC Columns for Increased Sample Throughput in Peptide Quantitation Nicole Hebert Eksigent Technologies Confirmed	60. Metlin: A Mass Spectrometry Web Database Application for Metabolite Characterization in Global Unbiased Metabolomics Kevin Y. Cho The Scripps Research Institute Confirmed
	62. A Liquid Chromatography Tandem Mass Spectrometry-Based Method for Analysis of Total Testosterone in Human Serum Michael Jarvis AB SCIEX Confirmed	64. Development of a Simple and Fast Method for the Measurement by LC-MS/MS of Salivary Cortisol, Androstenedione and Testosterone Bruno Casetta AB SCIEX Confirmed	66. Tranexamic Acid Quantitation in Cardiopulmonary Bypass Patients Using Ultra Performance LC-MS/MS Ross Molinaro Emory University Confirmed
	68. Neonatal Screening Test for Inherited Metabolic Disorders by Tandem Mass Spectrometry in Korea; Experience of the Eone Reference Laboratory for 3 years Cho Sung Eun Eone Reference Laboratory Confirmed	70. A Streamlined Method for Methylmalonic Acid (MMA) Quantitation in Serum using Automated Supported Liquid Extraction and LC-MS/MS Julia C. Drees Kaiser Permanente Regional Laboratories Confirmed	72.
	74. Validation of Immunosuppressant Calibrator and QC Reagents Using On-Line Extraction Coupled to LC-MS/MS Laura Bechtel Memorial Sloan Kettering Cancer Center Confirmed	76. Measurement of Urine Orotic Acid and Orotidine by UPLC-MS/MS Lis Schwarz ARUP Laboratories, Inc Confirmed	78. Mapping of Signaling Molecules within Biofilms in a System-Wide Fashion Jessica Karr UCSD Confirmed
	80. Challenges in Analysis of Testosterone/Epitestosterone in Urine by LC-MS/MS Koyuki Takenaka San Diego State University Confirmed

POSTERS: Tuesday Feb 8
Exhibit Hall: Attended from 2:00-3:00 PM
Includes All PosterSplashes Presented from the Podium Between 12:00-12:30PM
	31. LC-MS/MS Analysis of Buprenorphine and its Metabolites in Urine and the Importance of Norbuprenorphine Cross-Reactivity in an Immunoassay Screen Christine Moore Immunalysis Corporation Confirmed	33. UPLC-MS/MS Measurements of 25(OH) Vitamin D2 and 25(OH) Vitamin D3 in the Pediatric Population in Atlanta, GA at Latitude 33° North Charbel Abou Diwan Emory University Confirmed	35. A Simple and Fast Method for the Analysis of Water and Fat Soluble Vitamins in Cell Culture Media using HPLC-ESI-MS/MS Diane Schmiederer Biocrates Life Sciences AG Confirmed
	37. SRM-based LC-MS Method for Detection of Hemoglobin Variants at Hemoglobinopathies Diagnostics Oksana Gvozdyak ThermoFisher Scientific Confirmed	39. Toxicology: A Targeted LC-MS/MS Approach to a Rapid & Comprehensive Pain Management Analysis Peter Stone Agilent Technologies, Inc. Confirmed	41. Multifunctional Core-Shell Nanoparticles Provide a One-Step Solution for the Identification of Elusive Low-Abundance Clinical Biomarkers Benjamin Lepene Ceres Nanosciences Confirmed
	43. Unraveling Mixture Toxicity in Human Populations: Towards Standardized Umbilical Cord Blood Proteomics Nicole Hansmeier The Biodesign Institute at Arizona State University Confirmed	45. Detection of Levamisole Exposure in Cocaine Users by LC-MS/MS Kara L. Lynch University of California, San Francisco Confirmed	47. Development of a Candidate Reference Measurement Procedure for Determination of Phenytoin, Phenobarbital, Lamotrigine, and Topiramate in Human Serum Using Isotope-Dilution LC-MS/MS Susan Tai National Institute of Standards and Technology Confirmed
	49. Measuring Busulfan in Blood Plasma Using On-Line Extraction Coupled to LC-MS/MS by APCI and HESI Ryan C. Schofield Memorial Sloan-Kettering Cancer Center Confirmed	51. Reducing the Need for Technical Replicates - Implementation of Peptide QC Standards Scott Peterman ThermoFisher Scientific Confirmed	53. Analysis of Cortisol, Cortisone and Dexamethasone in Serum Using LC-MS/MS and Assessment of Cortisol: Cortisone Ratios in Patients with Impaired Kidney Function Julie A. Ray ARUP Laboratories Confirmed
	55. A Fast, Simple Method for the Analysis of Pain Management Drugs in Human Urine Utilizing LC-MS/MS John McFarlane AB SCIEX Confirmed	57. Detection of Age-Related Histone PTMs as M/Z Pair Tags in LC-MS Measurement of Mesenchymal Stem Cell Lysates Michael Athanas Vast Scientific Confirmed	59. Disulfide Mapping Verification using SIEVE Michael Athanas Vast Scientific Confirmed
	61. The Measurement of Free Thyroxine (T4) and Triiodothyronine (T3) Using a QTRAP®5500 LC/MS/MS System Brent Dawson AB Sciex Confirmed	63. Solvent Dependent Variability in Vitamin D Analysis Eduard Rogatsky Albert Einstein College of Medicine Confirmed	65. Rapid Detection of Resistance Against ß-lactam Antibiotics by MALDI-TOF MS Markus Kostrzewa Bruker Daltonik GmbH Confirmed
	67. Using In Vitro Model to Aid the Identification and Screening of Major Metabolites of K2 in Human Urine Brent Dawson AB Sciex Confirmed	69.	71. Quantification of Digoxin and its Metabolite Dihydrodigoxin by Mass Spectrometry and Implications for Cancer Therapeutics Steven M. Truscott University of Louisville Confirmed
	73. Analytical Performance of Mass Trak Kit for Tacrolimus and Cyclosporine Assay by LC-MS/MS Yeo Min Yun Konkuk University Hospital and School of Medicine Confirmed	75. Development of Targeted Screening Method for Drug of Abuse Using Ultraperformance LC-MS/MS Yeo Min Yun Konkuk University Hospital and School of Medicine Confirmed	77. A High-throughput LC-MS Assay for Drugs of Abuse in Urine Jan Palaty LifeLabs Medical Laboratories Confirmed
	79. Identification of Proteins in Plasma of Lung Cancer Patients and Control Groups Using the Combined LC-ESI-MS/MS Approach WITHDRAWN Valery Shevchenko N. N. Blokhin Russian Cancer Research Center
Exhibit Hall: Attended from 6:30-7:30 PM
Includes All PosterSplashes Presented from the Podium Between 4:30-5:00PM
	32. Intact and Functional Mitochondria from Solid Tissue: Effective Semi-Automated Extraction Using Gentle Mechanical Homogenization and Pressure Cycling Technology Vera Gross Pressure Biosciences, Inc. Confirmed	34. An LC-MS/MS Method for Simultaneous Analysis of Cyclosporin A and Tacrolimus in a Transplant Population and Comparison with the Abbott IMx and AxSYM, Respectively Marguerite MacMahon Mater Misericordiae University Hospital	36. Efficient Identification of Statistically Significant Protein Biomarker Candidate Panels by Generation of Multi-Marker ROC Curves Amol Prakash ThermoFisher Scientific Confirmed
	38. Anabolic Androgenic Steroid Testing by Liquid Chromatography Quadrupole Time-Of-Flight Mass Spectrometry in Urine Erica Angelique Guice Western Slope Laboratory, LLC Confirmed	40. LC-MS/MS Method for the Measurement of Serum Mevalonic Acid: A Novel Marker of HMG-CoA Reductase Inhibition by Statins Jenna Waldron Heart of England NHS Foundation Trust Confirmed	42. Multimode, Single-Shot Mass Spectrometry with Nanomechanical Devices Mehmet Selim Hanay California Institute of Technology Confirmed
	44. MALDI Mass Spectrometry with a Nanomechanical Resonator for Direct Mass Measurement of Neutral and Ionized Bioparticles Scott Kelber CalTech Confirmed	46. Generic LC-MS Method for Quantitative Analysis of Drugs in Human Urine Implementing Ultra-High Resolution Mass Spectrometer Exactive(TM) Marta Kozak Thermo Scientific Confirmed	48. UPLC-MS/MS Simultaneous Determination of Cocaine Metabolites and its Adulterant Levamisole in Urine Charbel Abou Diwan Emory University
	50. A Simplified Workflow for the Analysis of 25-Hydroxyvitamin D3 and 25-Hydroxyvitamin D2 using Commercially Available Plasma Calibrators and Controls and LC-MS/MS Michael Jarvis AB SCIEX Confirmed	52.	54. Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Two Korean Patients: Case Reports and Identification of a Novel ACADM Mutation Yong-Wha Lee Soonchunhyang University Confirmed
	56. Comparison of MALDI-TOF-MS and HPLC-ESI-MS/MS for Endopeptidase Activity Based Quantification of Anthrax Lethal Factor in Serum Zsuzsanna Kuklenyik CDC Confirmed	58. Selective Capture and Biosensing with Gold Nanorod Supported Lipid Bilayers Edward T. Castellana Texas A&M University Confirmed	60. Calcium Metabolism in Castration-Resistant Prostate Cancer Patients: Development of a Quantitative Urinary Assay for Extent of Bone Metastasis Darren Hillegonds Lawrence Livermore Nat'l Lab Confirmed
	62. Quantitation of Benzodiazepines, Opiates, Amphetamines and Recreational Drugs (B.O.A.R.D panel)in Urine by LC-MS/MS Susan C. Leonard AB Sciex Confirmed	64. Evaluating the Relationship of Carisoprodol Concentrations and Meprobamate Formation in Pain Patients Stephanie Tse University of California, San Diego Confirmed	66. Direct and Fast Identification of Bacteria from Positively Flagged Blood Cultures Using MALDI-TOF MS Markus Kostrzewa Bruker Daltonik GmbH Confirmed
	68. Automated Solid Phase Extraction of Plasma Metanephrine, Normetanephrine and 3-Methoxytyramine for Analysis by LC-MS/MS Lisa Calton Waters Corporation Confirmed	70. Analysis of Fentanyl and Its Metabolites in Human Urine with Ultra-High Resolution Exactive Benchtop Mass Spectrometer Coupled to High Performance Liquid Chromatography Xiang He ThermoFisher Scientific Confirmed	72. Validation of SAMHSA Guideline Compliant LC-MS Method for the Newly Expanded NIDA 5 Panel Using Ultra-High Resolution Accurate Mass Exactive Mass Spectrometer Xiang He ThermoFisher Scientific Confirmed
	74. Analysis of Phthalate Metabolites in Human Urine, MARBLES Study Rana Zahedi California Department of Public Health Confirmed	76. A Pilot Study on the Determination of Persistent Organic Pollutants in Dried Blood Spots from Newborn Screening Program of New York State Chunyang Liao State University of New York at Albany Confirmed	78. Improved Sensitivity and Speed of Fatty Acid Analysis by Orbitrap Mass Spectrometry from any Biological Matrix Xingnan Li Cancer Research Center of Hawaii Confirmed
	80. Urinary Protein Profiles in Healthy Individuals, Patients with Proteinuria and Histoplasma Antigenuria Mark Kushnir ARUP Institute for Clinical and Experimental Pathology Confirmed

Exhibits

Exhibit Hall Hours Sun 3:00-7:30 PM Reception Mon 12:30-3:00 PM Lunch Mon 5:00-7:30 PM Reception Tue 12:30-3:00 PM Lunch Tue 5:00-7:30 PM Reception

Golden West Biologicals Booth A

MicroLiter Analytical Supplies Booth B

Nonlinear Dynamics Booth C

Geneva Bioinformatics (GeneBio) Booth D

Biotage Booth 1

Imtakt Booth 2

Shimadzu Scientific Instruments Booth 3

Metabolon Booth 4

Parker Hannifin Booth 5

TBA Booth 6

SP Scientific Booth 7

Pressure BioSciences Booth 8

IONICS Mass Spectrometry Group Booth 9

Tecan Booth 10

Agilent Technologies Booth 11

Peak Scientific Instruments Booth 12

Abbott Booth 13

PerkinElmer Booth 14

Chromsystems Booth 15

AB Sciex Booth 16

Cambridge Isotope Labs Booth 17

Biocius Life Sciences Booth 18

Indigo Biosystems Booth 19

Waters Booth 20

BIOCRATES Life Sciences Booth 21

IsoSciences Booth 22

Thermo Scientific Booth 23

Thermo Scientific Booth 24

Cerilliant Booth 25

Phenomenex Booth 26

Bruker Daltonics Booth 27

Michrom Bioresources Booth 28

Exhibit Hall Diagram